Atrial Fibrillation Characteristics in Patients on Haemodialysis vs. Peritoneal Dialysis

被引:11
作者
Abuhasira, Ran [1 ,2 ]
Mizrakli, Yuval [1 ,2 ]
Shimony, Avi [3 ,5 ]
Novack, Victor [2 ,5 ]
Shnaider, Alla [4 ,5 ]
Haviv, Yosef S. [4 ,5 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Joyce & Irving Goldman Med Sch, Beer Sheva, Israel
[2] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel
[3] Soroka Univ, Med Ctr, Dept Cardiol, Beer Sheva, Israel
[4] Soroka Univ, Med Ctr, Dept Nephrol, Beer Sheva, Israel
[5] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
来源
SCIENTIFIC REPORTS | 2018年 / 8卷
关键词
STAGE RENAL-DISEASE; RISK-FACTORS; STROKE; INSIGHTS; WARFARIN;
D O I
10.1038/s41598-018-21229-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Atrial fibrillation (AF) is highly prevalent in dialysis patients, however whether its impact differs between patients on haemodialysis (HD) vs. peritoneal dialysis (PD) is unknown. We aimed to compare the association of AF and clinical outcomes in different dialysis modalities. We performed a population based retrospective cohort study, including adult patients who initiated dialysis between the years 2002 and 2015. Clinical, echocardiographic and laboratory data were reviewed and correlated with outcomes in HD vs. PD. During the study period, 1,130 patients began dialysis. Of the 997 patients without AF before dialysis initiation, 17% developed new-onset AF after the initiation of dialysis (17.3% of HD vs. 13.7% of PD patients, p = 0.27). Using multivariate analysis, only enlarged left atrium at dialysis initiation (hazard ratio (HR) 2.82, CI95% 2.00-3.99) and age (HR 1.04, CI95% 1.03-1.06) were significantly associated with AF. Dialysis modality was not a significant predictor of AF in either univariate or multivariate analysis. In conclusion, our study demonstrated that AF is common in dialysis patients irrespective of modality. In our cohort, the risk factors associated with AF were older age and enlarged left atrium. AF was associated with increased rates of heart failure and mortality, but not stroke.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry
    Yamashita, Yugo
    Takagi, Daisuke
    Hamatani, Yasuhiro
    Iguchi, Moritake
    Masunaga, Nobutoyo
    Esato, Masahiro
    Chun, Yeong-Hwa
    Itoh, Hitoshi
    Nishimura, Masato
    Wada, Hiromichi
    Hasegawa, Koji
    Ogawa, Hisashi
    Abe, Mitsuru
    Akao, Masaharu
    HEART AND VESSELS, 2016, 31 (12) : 2025 - 2034
  • [2] Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?
    To, Andrew Cy
    Yehia, Maha
    Collins, John F.
    NEPHROLOGY, 2007, 12 (05) : 441 - 447
  • [3] Atrial fibrillation in incident dialysis patients
    Vazquez, Eduardo
    Sanchez-Perales, Carmen
    Garcia-Garcia, Francisco
    Castellano, Patricia
    Garcia-Cortes, Maria-Jose
    Liebana, Antonio
    Lozano, Cristobal
    KIDNEY INTERNATIONAL, 2009, 76 (03) : 324 - 330
  • [4] The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients
    Buiten, M. S.
    de Bie, M. K.
    Rotmans, J. I.
    Gabreels, B. A.
    van Dorp, W.
    Wolterbeek, R.
    Trines, S. A.
    Schalij, M. J.
    Jukema, J. W.
    Rabelink, T. J.
    van Erven, L.
    HEART, 2014, 100 (09) : 685 - 690
  • [5] Bleeding risk of haemodialysis and peritoneal dialysis patients
    van der Sluijs, Anita van Eck
    Abrahams, Alferso C.
    Rookmaaker, Maarten B.
    Verhaar, Marianne C.
    Bos, Willem Jan W.
    Blankestijn, Peter J.
    Dekker, Friedo W.
    van Diepen, Merel
    Ocak, Gurbey
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (01) : 170 - 175
  • [6] Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF
    Chen, Sean T.
    Hellkamp, Anne S.
    Becker, Richard C.
    Berkowitz, Scott D.
    Breithardt, Guenter
    Fox, Keith A. A.
    Hacke, Werner
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Mahaffey, KennethW.
    Nessel, Christopher C.
    Piccini, Jonathan P.
    Singer, Daniel E.
    Patel, Manesh R.
    Melloni, Chiara
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2019, 5 (02) : 145 - 152
  • [7] Atrial Fibrillation in Dialysis Patients: A Neglected Comorbidity
    Atta, Mohamed G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02): : 203 - 205
  • [8] Atrial fibrillation and risk of stroke in dialysis patients
    Wetmore, James B.
    Ellerbeck, Edward F.
    Mahnken, Jonathan D.
    Phadnis, Milind
    Rigler, Sally K.
    Mukhopadhyay, Purna
    Spertus, John A.
    Zhou, Xinhua
    Hou, Qingjiang
    Shireman, Theresa I.
    ANNALS OF EPIDEMIOLOGY, 2013, 23 (03) : 112 - 118
  • [9] Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation
    O'Donoghue, Michelle L.
    Ruff, Christian T.
    Giugliano, Robert P.
    Murphy, Sabina A.
    Grip, Laura T.
    Mercuri, Michele F.
    Rutman, Howard
    Shi, Minggao
    Kania, Grzegorz
    Cermak, Ondrej
    Braunwald, Eugene
    Antman, Elliott M.
    EUROPEAN HEART JOURNAL, 2015, 36 (23) : 1470 - +
  • [10] Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis
    Chan, Pak-Hei
    Huang, Duo
    Yip, Pok-Siu
    Hai, Jojo
    Tse, Hung-Fat
    Chan, Tak-Mao
    Lip, Gregory Y. H.
    Lo, Wai-Kei
    Siu, Chung-Wah
    EUROPACE, 2016, 18 (05): : 665 - 671